• Now Available! Now Available!

    NOW AVAILABLE

    Learn more about the new HTG EdgeSeq Pan B-Cell Lymphoma Panel

    Learn More

  • Now Available! Now Available!
  • Now Available! Now Available!

    NOW AVAILABLE

    Learn more about the new HTG EdgeSeq Autoimmune Panel

    Learn More

  • Now Available! Now Available!

    NOW AVAILABLE

    HTG EdgeSeq Reveal - a new data analysis tool from HTG

    Learn More

  • Now Available! Now Available!

    NOW AVAILABLE

    Learn more about HTG’s new Precision Immuno-Oncology Panel

    Learn More

 

USE HTG

Hear how HTG Molecular is committed to collaborating with our investigators around the globe to address key diagnostic and therapeutic questions that can eventually be translated to empower precision medicine at the local level.

As an example, at the ASCO 2019 Clinical Science Symposium, Dr. William from M.D. Anderson and Hospital BP in Sao Paulo Brazil presented an interesting body of work around the molecular landscape of oral neoplasias and the risk of progression to malignancy.

Learn More

A Revolution in Molecular Profiling

Our next-generation sequencing (NGS)-adapted chemistry and instrument platforms automate sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets from samples a fraction of the size required by competitive technologies, enabling customers to do more molecular profiling with less sample.

Learn More

Now Available

HTG EdgeSeq Pan B-Cell Lymphoma panel.  The newest addition to our RUO portfolio.  It is designed to provide molecular characterization of aggressive lymphomas by allowing researchers to measure the expression of genes associated with the lymphoma transcriptome.

  • Overcome sample input limitations using HTG's proprietary extraction-free chemistry and low sample input
  • Identify molecular sub-typing algorithms using HTG EdgeSeq Reveal software - a web-based biostatistical analysis tool
  • Compatibility with Illumina and Thermo Fisher Scientific NGS sequencers

 

News & Events

HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11

TUCSON, Ariz. , Aug. 05, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2020 after the market close on

Keep Reading

HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications

TUCSON, Ariz. , Aug. 04, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to

Keep Reading

HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays

Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform TUCSON, Ariz. , July 30, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine,

Keep Reading

HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel

TUCSON, Ariz. , July 28, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch and immediate availability of the HTG EdgeSeq Pan B-Cell Lymphoma Panel in the United States and

Keep Reading

HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants

TUCSON, Ariz., July 23, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced Vinodh Pillai, M.D., Ph.D., Assistant Professor of Pathology and Laboratory Medicine at the Children’s Hospital of Philadelphia, and Thomas Dörner, MD, Professor of Rheumatology and Hemostaseology at Charité University Hospitals, Berlin, as award recipients of its 2020 HTG EdgeSeq Autoimmune Panel Research Grants.

Posted on:

Keep Reading

HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants

Researchers at University of Pennsylvania Perelman School of Medicine and Charité University Hospitals, Berlin recognized for cutting edge work in autoimmune diseases TUCSON, Ariz. , July 23, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company

Keep Reading

Careers at HTG

At HTG Molecular Diagnostics, Inc., we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

Featured Positions

Sr. Manager, Molecular Testing Laboratory

Sr. Manager/Director Assay Development

Sample Logistics Specialist

New Careers

Helpdesk Technican

Scientist, Scientific Services

See All Careers


Resources

Find product information, specifications and gene lists here. 

Case Studies

Brochures

Gene Lists

Product Sheets

Tech Notes

Safety Data Sheets

Videos


Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Support

Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or assays. 

Product Launch Files

User Manuals RUO

User Manuals CE-IVD

Package Inserts RUO

Package Inserts CE-IVD

Training Modules RUO

Training Modules CE-IVD

Deployer Software Downloads

HTG Software Downloads

Page last updated July 27, 2020

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch